Search

everythinglearnresearchcommunity

for

Search:↓

An injectable ibuprofen gel speeds up diabetic wound healing by reducing inflammation and promoting tissue growth.

Topical tofacitinib helped a man with severe scalp condition after other treatments failed.

Baricitinib effectively and safely improves hair growth in patients with severe alopecia areata.

Isoalantolactone promotes hair growth by activating specific cell pathways.

IBD treatment is complex and requires personalized approaches due to varying patient responses.

Access to JAK inhibitor therapy for alopecia areata patients is difficult, especially for racial minorities.

JAK inhibitors effectively and safely treat alopecia areata with few serious side effects.

Skin issues and diarrhea can signal ulcerative colitis, needing further checks.

SII is a useful and affordable tool to assess and monitor alopecia areata.

A genetic defect causes males in some Mediterranean populations to be born with ambiguous genitalia and develop male traits at puberty.

A woman with alopecia regrew her hair after taking a higher dose of tocilizumab.

Basal cell carcinomas may use IDO to protect themselves from the immune system.

Baricitinib helps with early hair regrowth in people with alopecia areata.

Oral difelikefalin significantly reduces itch in notalgia paresthetica.

MYB30 and EIN3 work against each other to control root hair growth and phosphorus uptake in plants when phosphate is low.

Potassium iodide prevents hair loss and reduces toxicity from thallium acetate.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Anti-Ku-positive patients often have muscle weakness and autophagy plays a key role in their condition.

Talc in street cocaine can cause immune-reactive skin nodules where injected.

Baricitinib successfully regrew hair in an 8-year-old boy with alopecia totalis linked to a KRT74 gene variant.

α3β1 integrin is essential for skin stability and proper wound healing.

A new therapy for a skin blistering condition has not been developed yet.

Baricitinib is effective and safe for severe alopecia areata, working similarly with or without an atopic background.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Drugs that block GSK-3 show promise for treating various diseases.

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.

ILC1-like cells can cause alopecia areata by disrupting hair follicle immunity, suggesting a new treatment approach.

IL-1β inhibits human hair follicle growth.